1. National Institute for Health and Clinical Excellence: Methylphenidate, atomoxetine and dexamfetamine for the treatment of attention deficit hyperactivity disorder in children and adolescents. Technology Appraisal 98. 2006, NICE, London, Available at:
http://www.nice.org.uk/TA9
2. Green H, McGinnity A, Meltzer H, Ford T, Goodman R: Mental Health of Children and Young People, Great Britain. 2004, Palgrave MacMillan, London
3. Nahlik J: Issues in Diagnosis of Attention-Deficit/Hyperactivity Disorder in Adolescents. Clin Pediatr. 2004, 43: 1-10. 10.1177/000992280404300101.
4. Kessler RC, Adler L, Barkley R, Biederman J, Connors CK, Demler O, Faraone S, Greenhill L, Howes MJ: The Prevalence and Correlates of Adult ADHD in the United States: Results From the National Comorbidity Survey Replication. Am J Psychiatry. 2006, 163: 716-723. 10.1176/appi.ajp.163.4.716.
5. National Institute for Health and Clinical Excellence: Attention deficit hyperactivity disorder: pharmacological and psychological interventions in children, young people and adults. 2008, The British Psychological Society and the Royal College of Psychiatrists, London, Available at:
http://guidance.nice.org.uk/CG72